Lv4
460 积分 2025-01-21 加入
Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection
5天前
已完结
Physiologically-Based Pharmacokinetic Modeling for Drugs Cleared by Non-Cytochrome P450 Enzymes: State-of-the-Art and Future Perspectives
7天前
已完结
Frequency and distribution of H1N1 influenza A viruses with oseltamivir‐resistant mutations worldwide before and after the 2009 pandemic
7天前
已完结
Baloxavir Marboxil: A Review in Acute Uncomplicated Influenza
9天前
已完结
Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: a phase 1 double-blind study in healthy subjects
14天前
已完结
Pharmacokinetic Properties ofAnti‐Influenza Neuraminidase Inhibitors
14天前
已完结
Population Pharmacokinetics of Peramivir in Healthy Volunteers and Influenza Patients
14天前
已完结
Pharmacokinetic Properties of Peramivir After Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers
14天前
已完结
Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy Volunteers
15天前
已完结
Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802
15天前
已完结
皖公网安备34019202002308
